Izhar Wallach is the founder of Atomwise. Atomwise has raised $170M in total funding. Latest round: Series B. Backed by Bayer's Leaps.
Izhar Wallach is the co-founder of Atomwise, an AI-powered drug discovery company that utilizes the AtomNet platform to identify novel chemical matter for therapeutic targets. He has been involved with Atomwise since its founding in February 2018 when Bayer's Leaps initiative made its initial investment.
Full founder directory · Investor directory · Company funding database · Fundraising library